venBio Global Strategic Fund II L.P.

Insider Reports History

Location
San Francisco, CA
Signature
venBio Global Strategic Fund II, L.P., by: venBio Global Strategic GP II, L.P., its general partner, by: venBio Global Strategic GP II, Ltd., its general partner, by: /s/ David Pezeshki, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by venBio Global Strategic Fund II L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Checkmate Pharmaceuticals, Inc. 10%+ Owner Common Stock 2,155,930 $22,529,253 $10.45 16 May 2022 Direct

Insider Reports Filed by venBio Global Strategic Fund II L.P.